Synthesis of Novel Donor‐π‐Acceptor Benzothiazole‐Thiazolidinone Fluorescent Chromophores With Enhanced Biological Activity
Luminescence · 2025
DOI: 10.1002/bio.70125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Luminescence, 2025. Verfasst von Haifa Alharbi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Science, Northern Border University, Arar, Saudi Arabia. Hauptthemen laut MEDLINE: Benzothiazoles, Antineoplastic Agents, Thiazolidines, Fluorescent Dyes. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Deanship of Scientific Research at Northern Border University.
Abstract (Originalsprache)
Four benzothiazole‐thiazolidine‐4‐one derivatives 6 and 7a–c were prepared, and their chemical constructions were proved by IR, NMR, UV–Vis absorption, and emission spectra. The absorption spectra of the synthesized derivatives showed that extending the conjugated system through the insertion of a substituted benzylidene group led to a red shift of λ max , where the nitro derivative 7c displayed the longer wavelength. Likewise, the emission spectra presented the same effect, where the Stock shift displayed a reversed order in which the parent 6 has the highest value. The synthesized derivatives exhibited cytotoxic effectiveness against several tumor cell lines, where compound 7b displayed significant cytotoxicity towards MCF‐7 cells (IC 50 = 8.73 ± 0.41 μM). The in vitro VEGFR‐2 kinase inhibitory activity of synthetic benzothiazole‐thiazolidin‐4‐one derivatives has been assessed, where derivative 7c had the strongest inhibition (IC 50 = 0.20 ± 0.10 μM), followed by derivatives 7b and 7a , respectively. However, the molecular docking showed that derivatives 7b and 7c have higher binding affinity than Sorafenib due to unique molecular interactions with target residues. Moreover, the pharmacokinetic parameters of the newly synthesized derivatives showed that derivative 7b revealed moderate lipophilicity and a lack of Lipinski violations, making it a viable lead contender.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Science, Northern Border University, Arar, Saudi Arabia.
- Department of Chemistry, Faculty of Science, Umm Al Qura University, Makkah, Saudi Arabia.
- Department of Biology/Genetic and Molecular Biology Central Laboratory (GMCL), Jamoum University College, Umm Al-Qura University, Makkah, Saudi Arabia.
- Department of Physics, College of Science, University of Tabuk, Tabuk, Saudi Arabia.
- Department of Physics, College of Science and Humanities, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- Department of Chemistry, College of Science, University of Tabuk, Tabuk, Saudi Arabia.
ORCID-Profile: Nashwa M El-Metwaly
Förderung
- Deanship of Scientific Research at Northern Border University
Zitieren
APA
Alharbi, H., Alsharief, H. H., Alrefaei, A. F., Alsharari, A. M., Al-Ghamdi, S. A., Aldosari, F. M., Alatawi, I. S. S., & El-Metwaly, N. M. (2025). Synthesis of Novel Donor‐π‐Acceptor Benzothiazole‐Thiazolidinone Fluorescent Chromophores With Enhanced Biological Activity. Luminescence. https://doi.org/10.1002/bio.70125
Vancouver
Alharbi H, Alsharief HH, Alrefaei AF, Alsharari AM, Al-Ghamdi SA, Aldosari FM, et al. Synthesis of Novel Donor‐π‐Acceptor Benzothiazole‐Thiazolidinone Fluorescent Chromophores With Enhanced Biological Activity. Luminescence. 2025. doi:10.1002/bio.70125
BibTeX
@article{Alharbi2025,
author = {Alharbi, Haifa and Alsharief, Hatun H and Alrefaei, Abdulmajeed F and Alsharari, Abdulrhman M and Al-Ghamdi, S A and Aldosari, F M and Alatawi, Ibrahim S S and El-Metwaly, Nashwa M},
title = {Synthesis of Novel Donor‐π‐Acceptor Benzothiazole‐Thiazolidinone Fluorescent Chromophores With Enhanced Biological Activity},
journal = {Luminescence},
year = {2025},
doi = {10.1002/bio.70125}
}
EUVIMED